KLRC1 and non-Hodgkin lymphoma: CD40L and IL-4 increased HLA-E expression on the surface of primary CLL cells and non-Hodgkin’s lymphoma (NHL) cell lines, and this decreased NK cell-mediated ADCC via ligation of the inhibitory receptor NKG2A.